866-997-4948(US-Canada Toll Free)

Japan Retinal Drugs Market Research Report 2018

Published By :

QYResearch

Published Date : Jun 2018

Category :

Pharmaceutical

No. of Pages : 102 Pages

The global Retinal Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Japan plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Retinal Drugs development status and future trend in Japan, focuses on top players in Japan, also splits Retinal Drugs by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Japan market include
Alcon (Novartis AG)
Johnson and Johnson Vision
Bausch and Lomb
Regeneron Pharmaceuticals
Alimera Sciences
Janssen Biotech
Genzyme Corporation
Ocular Therapeutix

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Anti-allergy
Anti-inflammatory
Anti-glaucoma
Anti-VEGF Agents

On the basis of the end users/Application, this report covers
Hospital Pharmacies
Retail Pharmacies
Specialty Ophthalmology Clinics
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Japan Retinal Drugs Market Research Report 2018
1 Retinal Drugs Overview
1.1 Product Overview and Scope of Retinal Drugs
1.2 Classification of Retinal Drugs by Product Category
1.2.1 Japan Retinal Drugs Sales (K MT) Comparison by Type (2013-2025)
1.2.2 Japan Retinal Drugs Sales (K MT) Market Share by Type in 2017
1.2.3 Anti-allergy
1.2.4 Anti-inflammatory
1.2.5 Anti-glaucoma
1.2.6 Anti-VEGF Agents
1.3 Japan Retinal Drugs Market by Application/End Users
1.3.1 Japan Retinal Drugs Sales (K MT) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Specialty Ophthalmology Clinics
1.3.5 Others
1.4 Japan Revenue and Sales of Retinal Drugs (2013-2025)
1.4.1 Japan Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2025)
1.4.2 Japan Retinal Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 Japan Retinal Drugs Market Competition by Players/Manufacturers
2.1 Japan Retinal Drugs Sales (K MT) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Japan Retinal Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Japan Retinal Drugs Average Price (USD/MT) by Players/Manufacturers (2013-2018)
2.4 Japan Retinal Drugs Market Competitive Situation and Trends
2.4.1 Japan Retinal Drugs Market Concentration Rate
2.4.2 Japan Retinal Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.5 Japan Players/Manufacturers Retinal Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 Japan Retinal Drugs Sales and Revenue (Value) by Type (2013-2018)
3.1 Japan Retinal Drugs Sales (K MT) and Market Share by Type/ Product Category (2013-2018)
3.2 Japan Retinal Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Japan Retinal Drugs Price (USD/MT) by Type (2013-2018)
3.4 Japan Retinal Drugs Sales Growth Rate (%) by Type (2013-2018)

4 Japan Retinal Drugs Sales by Application (2013-2018)
4.1 Japan Retinal Drugs Sales (K MT) and Market Share by Application (2013-2018)
4.2 Japan Retinal Drugs Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 Japan Retinal Drugs Players/Suppliers Profiles and Sales Data
5.1 Alcon (Novartis AG)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Retinal Drugs Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Alcon (Novartis AG) Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 Johnson and Johnson Vision
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Retinal Drugs Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 Johnson and Johnson Vision Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Bausch and Lomb
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Retinal Drugs Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Bausch and Lomb Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 Regeneron Pharmaceuticals
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Retinal Drugs Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 Regeneron Pharmaceuticals Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Alimera Sciences
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Retinal Drugs Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Alimera Sciences Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Janssen Biotech
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Retinal Drugs Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Janssen Biotech Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
5.7 Genzyme Corporation
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Retinal Drugs Product Category, Application and Specification
5.7.2.1 Product A
5.7.2.2 Product B
5.7.3 Genzyme Corporation Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
5.7.4 Main Business/Business Overview
5.8 Ocular Therapeutix
5.8.1 Company Basic Information, Manufacturing Base and Competitors
5.8.2 Retinal Drugs Product Category, Application and Specification
5.8.2.1 Product A
5.8.2.2 Product B
5.8.3 Ocular Therapeutix Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
5.8.4 Main Business/Business Overview

6 Retinal Drugs Manufacturing Cost Analysis
6.1 Retinal Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Retinal Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Retinal Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Retinal Drugs Major Manufacturers in 2017
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 Japan Retinal Drugs Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 Japan Retinal Drugs Sales (K MT), Revenue (Million USD) Forecast (2018-2025)
10.2 Japan Retinal Drugs Sales (K MT) Forecast by Type (2018-2025)
10.3 Japan Retinal Drugs Sales (K MT) Forecast by Application (2018-2025)

11 Research Findings and Conclusion


List of Table

List of Tables and Figures

Figure Japan Market Size (Million USD) Status and Outlook (2013-2025)
Table Retinal Drugs Sales (K MT) and Revenue (Million USD) Market Split by Product Type
Table Retinal Drugs Sales (K MT) by Application (2017-2025)
Figure Product Picture of Retinal Drugs
Table Japan Retinal Drugs Sales (K MT) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Japan Retinal Drugs Sales Volume Market Share by Type in 2017
Figure Anti-allergy Product Picture
Figure Anti-inflammatory Product Picture
Figure Anti-glaucoma Product Picture
Figure Anti-VEGF Agents Product Picture
Figure Japan Retinal Drugs Sales (K MT) Comparison by Application (2013-2025)
Figure Japan Sales Market Share (%) of Retinal Drugs by Application in 2017
Figure Hospital Pharmacies Examples
Figure Retail Pharmacies Examples
Figure Specialty Ophthalmology Clinics Examples
Figure Others Examples
Figure Japan Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2025)
Figure Japan Retinal Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Japan Retinal Drugs Sales of Key Players/Manufacturers (2013-2018)
Table Japan Retinal Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan Retinal Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 Japan Retinal Drugs Sales Share (%) by Players/Manufacturers
Table Japan Retinal Drugs Revenue by Players/Manufacturers (2013-2018)
Table Japan Retinal Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Japan Retinal Drugs Revenue Share (%) by Players/Manufacturers
Figure 2017 Japan Retinal Drugs Revenue Share (%) by Players/Manufacturers
Table Japan Market Retinal Drugs Average Price (USD/MT) of Key Players/Manufacturers (2013-2018)
Figure Japan Market Retinal Drugs Average Price (USD/MT) of Key Players/Manufacturers in 2017
Figure Japan Retinal Drugs Market Share of Top 3 Players/Manufacturers
Figure Japan Retinal Drugs Market Share of Top 5 Players/Manufacturers
Table Japan Players/Manufacturers Retinal Drugs Manufacturing Base Distribution and Sales Area
Table Japan Players/Manufacturers Retinal Drugs Product Category
Table Japan Retinal Drugs Sales (K MT) by Type (2013-2018)
Table Japan Retinal Drugs Sales Share (%) by Type (2013-2018)
Figure Japan Retinal Drugs Sales Share (%) by Type (2013-2018)
Figure Japan Retinal Drugs Sales Market Share (%) by Type in 2017
Table Japan Retinal Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Japan Retinal Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Retinal Drugs by Type (2013-2018)
Figure Revenue Market Share of Retinal Drugs by Type in 2017
Table Japan Retinal Drugs Price (USD/MT) by Type (2013-2018)
Figure Japan Retinal Drugs Sales Growth Rate (%) by Type (2013-2018)
Table Japan Retinal Drugs Sales (K MT) by Application (2013-2018)
Table Japan Retinal Drugs Sales Market Share (%) by Application (2013-2018)
Figure Japan Retinal Drugs Sales Market Share (%) by Application (2013-2018)
Figure Japan Retinal Drugs Sales Market Share (%) by Application in 2017
Table Japan Retinal Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure Japan Retinal Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Alcon (Novartis AG) Retinal Drugs Basic Information List
Table Alcon (Novartis AG) Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Alcon (Novartis AG) Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Alcon (Novartis AG) Retinal Drugs Sales Market Share (%) in Japan (2013-2018)
Figure Alcon (Novartis AG) Retinal Drugs Revenue Market Share (%) in Japan (2013-2018)
Table Johnson and Johnson Vision Retinal Drugs Basic Information List
Table Johnson and Johnson Vision Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Johnson and Johnson Vision Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Johnson and Johnson Vision Retinal Drugs Sales Market Share (%) in Japan (2013-2018)
Figure Johnson and Johnson Vision Retinal Drugs Revenue Market Share (%) in Japan (2013-2018)
Table Bausch and Lomb Retinal Drugs Basic Information List
Table Bausch and Lomb Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Bausch and Lomb Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Bausch and Lomb Retinal Drugs Sales Market Share (%) in Japan (2013-2018)
Figure Bausch and Lomb Retinal Drugs Revenue Market Share (%) in Japan (2013-2018)
Table Regeneron Pharmaceuticals Retinal Drugs Basic Information List
Table Regeneron Pharmaceuticals Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Regeneron Pharmaceuticals Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Regeneron Pharmaceuticals Retinal Drugs Sales Market Share (%) in Japan (2013-2018)
Figure Regeneron Pharmaceuticals Retinal Drugs Revenue Market Share (%) in Japan (2013-2018)
Table Alimera Sciences Retinal Drugs Basic Information List
Table Alimera Sciences Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Alimera Sciences Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Alimera Sciences Retinal Drugs Sales Market Share (%) in Japan (2013-2018)
Figure Alimera Sciences Retinal Drugs Revenue Market Share (%) in Japan (2013-2018)
Table Janssen Biotech Retinal Drugs Basic Information List
Table Janssen Biotech Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Janssen Biotech Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Janssen Biotech Retinal Drugs Sales Market Share (%) in Japan (2013-2018)
Figure Janssen Biotech Retinal Drugs Revenue Market Share (%) in Japan (2013-2018)
Table Genzyme Corporation Retinal Drugs Basic Information List
Table Genzyme Corporation Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Genzyme Corporation Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Genzyme Corporation Retinal Drugs Sales Market Share (%) in Japan (2013-2018)
Figure Genzyme Corporation Retinal Drugs Revenue Market Share (%) in Japan (2013-2018)
Table Ocular Therapeutix Retinal Drugs Basic Information List
Table Ocular Therapeutix Retinal Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Ocular Therapeutix Retinal Drugs Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Ocular Therapeutix Retinal Drugs Sales Market Share (%) in Japan (2013-2018)
Figure Ocular Therapeutix Retinal Drugs Revenue Market Share (%) in Japan (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Retinal Drugs
Figure Manufacturing Process Analysis of Retinal Drugs
Figure Retinal Drugs Industrial Chain Analysis
Table Raw Materials Sources of Retinal Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Retinal Drugs
Table Distributors/Traders List
Figure Japan Retinal Drugs Sales (K MT) and Growth Rate (%) Forecast (2018-2025)
Figure Japan Retinal Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Retinal Drugs Price (USD/MT) Trend Forecast (2018-2025)
Table Japan Retinal Drugs Sales (K MT) Forecast by Type (2018-2025)
Figure Japan Retinal Drugs Sales (K MT) Forecast by Type (2018-2025)
Figure Japan Retinal Drugs Sales Volume Market Share Forecast by Type in 2025
Table Japan Retinal Drugs Sales (K MT) Forecast by Application (2018-2025)
Figure Japan Retinal Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure Japan Retinal Drugs Sales Volume Market Share Forecast by Application in 2025

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *